Brain-neuron targeted nanoparticles for peptide synergy therapy at dual-target of Alzheimer's disease-Reference-Cited by-同舟云学术

Brain-neuron targeted nanoparticles for peptide synergy therapy at dual-target of Alzheimer's disease

Published:2023-03 Issue: Volume:355 Page:604-621
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Guo Qian,Li Yixian,Xu Shuting,Wang Pengzhen,Qian Kang,Yang Peng,Sheng Dongyu,Wang Liuchang,Cheng Yunlong,Meng Ran,Cao Jinxu,Luo Haichang,Wei Yan,Zhang Qizhi

Funder

Natural Science Foundation of Shanghai

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference70 articles.

1. Amyloid-β-independent regulators of tau pathology in Alzheimer disease;van der Kant;Nat. Rev. Neurosci.,2020

2. Alzheimer's disease;Scheltens;Lancet,2021

3. Alzheimer mechanisms and therapeutic strategies;Huang;Cell,2012

4. Tau-targeting therapies for Alzheimer disease;Congdon;Nat. Rev. Neurol.,2018

5. Role of amyloid-β and tau proteins in Alzheimer’s disease: confuting the amyloid Cascade;Gulisano;J. Alzheimers Dis.,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Borneol and lactoferrin dual-modified crocetin-loaded nanoliposomes enhance neuroprotection in HT22 cells and brain targeting in mice;European Journal of Medicinal Chemistry;2024-10

2. Cytoskeleton-modulating nanomaterials and their therapeutic potentials;Advanced Drug Delivery Reviews;2024-08

3. Harnessing nanomedicine for modulating microglial states in the central nervous system disorders: Challenges and opportunities;Biomedicine & Pharmacotherapy;2024-08

4. Revolutionizing Alzheimer's treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements;Ageing Research Reviews;2024-08

5. Precision drug delivery to the central nervous system using engineered nanoparticles;Nature Reviews Materials;2024-06-25